FOXO Technologies Inc.

FOXO

OTC

Healthcare

Medical - Healthcare Information Services

West Palm Beach, MN, US102 employeesfoxotechnologies.com

—

At a Glance

AI-generated

Revenue breakdown: Health Cares (95.8%), Labs And Life (4.2%).

8-K

On March 27, 2026, the Majority Stockholder of FOXO Technologies Inc. — Rennova Health, Inc., controlled by the Company’s CEO — approved by written consent an amendment to increase the authorized Class A Common Stock from 10,000,000,000 to 25,000,000,000 shares, effective 20 days after mailing of the definitive Schedule 14C Information Statement.

—

Market Cap

—

Revenue

—

Net Income

Employees102

Fundamentals

How The Business Makes Money

Revenue by Segment

Health Cares95.8%($4M)

Labs And Life4.2%($177.9K)

Activity

What Changed Recently

Material Agreement

Feb 5, 2026

Entry into a Material Definitive Agreement. On February 6, 2026, FOXO Technologies Inc., a Delaware corporation (the “ Company ”), entered into a Series E Prefe

Shareholder Vote

Apr 1, 2026

| Submission of Matters to a Vote of Security Holders. | |---|---| On March 27, 2026, Rennova Health, Inc. (which is controlled by the Company’s CEO) (the “**Ma

Charter Amendment

Jan 19, 2026

by reference. Item 7.01 Regulation FD Disclosure. On January 20, 2026, the Company issued a press release which announced that its critical access-designated ac

Peer Companies

Company	Price	Change	Market Cap	P/E
PIIIP3 Health Partners Inc.	$2.52	-8.03%	$8M	-0.1
AKTXAkari Therapeutics, Plc	$4.60	-1.08%	$4M	—
ACONAclarion, Inc.	$3.56	+4.40%	$2M	—
REVBRevelation Biosciences, I...	$1.22	-0.80%	$2M	-0.8
DRMADermata Therapeutics, Inc...	$1.29	+7.38%	$878.3K	-0.2
VINCVincerx Pharma, Inc.	$0.01	-1.92%	$68.0K	-0.0
VRPXVirpax Pharmaceuticals, I...	$0.01	+0.00%	$13.7K	-0.0
SLXNWSilexion Therapeutics Ltd...	$0.01	-31.03%	$7.9K	-0.3

Company Profile

CIK0001812360

ISINUS3514715032

CUSIP351471503

Phone612-562-9447

Address729 North Washington Avenue, West Palm Beach, MN, 55401, US

SEC EDGAR